The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
Open accessAbstract
BACKGROUND: Lewy body disease is a heterogeneous group of neurodegenerative disorders characterized by alpha-synuclein accumulation that includes dementia with Lewy bodies (DLB) and Parkinson's Disease (PD). Recent evidence suggests that impairment of lysosomal pathways (i.e. autophagy) involved in alpha-synuclein clearance might play an important role. For this reason, we sought to examine the expression levels of members of the autophagy pathway in brains of patients with DLB and Alzheimer's Disease (AD) and in alpha-synuclein transgenic mice. METHODOLOGY/PRINCIPAL FINDINGS: By immunoblot analysis, compared to controls and AD, in DLB cases levels of mTor were elevated and Atg7 were reduced. Levels of other components of the autophagy pathway such as Atg5, Atg10, Atg12 and Beclin-1 were not different in DLB compared to controls. In DLB brains, mTor was more abundant in neurons displaying alpha-synuclein accumulation. These neurons also showed abnormal expression of lysosomal markers such as LC3, and ultrastructural analysis revealed the presence of abundant and abnormal autophagosomes. Similar alterations were observed in the brains of alpha-synuclein transgenic mice. Intra-cerebral infusion of rapamycin, an inhibitor of mTor, or injection of a lentiviral vector expressing Atg7 resulted in reduced accumulation of alpha-synuclein in transgenic mice and amelioration of associated neurodegenerative alterations. CONCLUSIONS/SIGNIFICANCE: This study supports the notion that defects in the autophagy pathway and more specifically in mTor and Atg7 are associated with neurodegeneration in DLB cases and alpha-synuclein transgenic models and supports the possibility that modulators of the autophagy pathway might have potential therapeutic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tsigelny, I. F., Crews, L., Desplats, P., Shaked, G. M., Sharikov, Y., Mizuno, H., Spencer, B., Rockenstein, E., Trejo, M., Platoshyn, O., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003135 · Cited by 281
Self-citationRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationIn Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 6×
“All cases met the Consortium to Establish a Registry for AD (CERAD) and National Institute of Aging (NIA) criteria for diagnosis and displayed neuritic plaques and tangle formation in the neocortex and limbic system [12,54].”
BackgroundMethodInfluentialSelf-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500 · cited 1×
“Furthermore, Atg7 deficiency results in neurodegeneration of the cerebral and cerebellar cortices [89].”
BackgroundRavikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“. Impaired clearance of the α-syn aggregates might play an important role in the pathogenesis of PD and DLB”
BackgroundMucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 1×
“. Furthermore, these animals also display neurodegenerative and behavioral deficits that mimic certain aspects of DLB. For western blot and immunocytochemical studies levels of components of the autophagy pathway were compared to littermate non tg controls and to an APP tg model (line J9M) of AD-like pathology. These…”
ResultSelf-citationMasliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Self-citationExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & -Y. Lee, V. M. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,546
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Death by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Boland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
Ravikumar, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1107 · Cited by 1,111
Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Blommaart, E. F. C., Krause, U., Schellens, J. P. M., Vreeling‐Sindelárová, H., & Meijer, A. J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0240a.x · Cited by 869
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., et al. (2005) · Nature Genetics · doi:10.1038/ng1609 · Cited by 822
Autophagy: in sickness and in health
Maria Cuervo, A. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.002 · Cited by 815
Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805
Pathoanatomy of Parkinson’s disease
Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693 · cited 2×
“For the present study we chose to focus on DLB because of its frequency and widespread accumulation of a-syn in neocortical and limbic structures [46,47,48].”
BackgroundMethodToggas, S. M., Masliah, E., Rockenstein, E. M., Rail, G. F., Abraham, C. R., & Mucke, L. (1994) · Nature · doi:10.1038/367188a0 · Cited by 682
Self-citationMcKeith, I. G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s347 · Cited by 625
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607
Self-citationSpencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595
Self-citationResistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
Dauer, W., Kholodilov, N., Vila, M., Trillat, A.-C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172514599 · Cited by 581
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256715.13907.d3 · Cited by 548
Self-citationEffects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease
Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.010 · Cited by 542
Self-citationRockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502
Self-citationHashimoto, M., Rockenstein, E., Crews, L., & Masliah, E. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:21 · Cited by 501
Self-citation(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
Eating Oneself and Uninvited GuestsAutophagy-Related Pathways in Cellular Defense
LEVINE, B. (2005) · Cell · doi:10.1016/s0092-8674(05)00043-7 · Cited by 455
Zhu, J.-H., Horbinski, C., Guo, F., Watkins, S., Uchiyama, Y., & Chu, C. T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060524 · Cited by 445
Oligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration.
Walsh, D., & Selkoe, D. (2004) · Protein & Peptide Letters · doi:10.2174/0929866043407174 · Cited by 428
Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W., & Kordower, J. H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.023 · Cited by 421
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
Parkinson, N., Ince, P. G., Smith, M. O., Highley, R., Skibinski, G., Andersen, P. M., Morrison, K. E., Pall, H. S., Hardiman, O., Collinge, J., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000231510.89311.8b · Cited by 395
Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice
Marr, R. A., Rockenstein, E., Mukherjee, A., Kindy, M. S., Hersh, L. B., Gage, F. H., Verma, I. M., & Masliah, E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-01992.2003 · Cited by 392
Self-citationAlzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy
Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359
Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., & Stefanis, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005515 · Cited by 354
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Tain, L. S., Mortiboys, H., Tao, R. N., Ziviani, E., Bandmann, O., & Whitworth, A. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2372 · Cited by 323
Sevlever, D., Jiang, P., & Yen, S.-H. C. (2008) · Biochemistry · doi:10.1021/bi800699v · Cited by 305
Litvan, I., MacIntyre, A., Goetz, C. G., Wenning, G. K., Jellinger, K., Verny, M., Bartko, J. J., Jankovic, J., McKee, A., Brandel, J. P., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.969 · Cited by 298
Organization of the Pre-autophagosomal Structure Responsible for Autophagosome Formation
Kawamata, T., Kamada, Y., Kabeya, Y., Sekito, T., & Ohsumi, Y. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1048 · Cited by 286
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Cullen, V., Lindfors, M., Ng, J., Paetau, A., Swinton, E., Kolodziej, P., Boston, H., Saftig, P., Woulfe, J., Feany, M. B., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-5 · Cited by 279
Pickford, F., Masliah, E., Britschgi, M., Lucin, K., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 268
Self-citationAutophagy in neurons: a review.
Larsen, K. E., & Sulzer, D. L. (2002) · PubMed · doi:10.14670/hh-17.897 · Cited by 241
Aggregate‐Prone Proteins Are Cleared from the Cytosol by Autophagy: Therapeutic Implications
Williams, A., Jahreiss, L., Sarkar, S., Saiki, S., Menzies, F. M., Ravikumar, B., & Rubinsztein, D. C. (2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76003-3 · Cited by 239
Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult
Lee, M., Hyun, D., Halliwell, B., & Jenner, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00149.x · Cited by 232
Neuropathology of Alzheimer’s disease: a critical update
Jellinger, K. A., & Bancher, C. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_8 · Cited by 231
Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease
Nixon, R. A., & Cataldo, A. M. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s331 · Cited by 222
Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9140-9 · Cited by 219
Self-citationMeredith, G. E., Totterdell, S., Petroske, E., Santa Cruz, K., Callison, R. C., & Lau, Y.-S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03514-x · Cited by 212
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
Pan, T., Kondo, S., Zhu, W., Xie, W., Jankovic, J., & Le, W. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.003 · Cited by 212
Autophagic Stress in Neuronal Injury and Disease
Chu, C. T. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229233.75253.be · Cited by 211 · cited 2×
“Recent evidence in cell-based models of PD-like pathology indicate that alterations in lysosomal functioning and autophagy might participate in the mechanisms of a-syn-mediated neurodegeneration [23,29,35,36,37,38,39].”
BackgroundAre Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?
Aarsland, D., Ballard, C. G., & Halliday, G. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267470 · Cited by 204
Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization
Tayebi, N., Callahan, M., Madike, V., Stubblefield, B. K., Orvisky, E., Krasnewich, D., Fillano, J. J., & Sidransky, E. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3201 · Cited by 200
The neuropathogenic contributions of lysosomal dysfunction
Bahr, B. A., & Bendiske, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01192.x · Cited by 180
Nutrient-dependent regulation of autophagy through the target of rapamycin pathway
Chang, Y.-Y., Juhász, G., Goraksha-Hicks, P., Arsham, A. M., Mallin, D. R., Muller, L. K., & Neufeld, T. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370232 · Cited by 173
SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA
McKeith, I. G., & Burn, D. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70230-9 · Cited by 168
Involvement of macroautophagy in the dissolution of neuronal inclusions
Rideout, H. J., Lang-Rollin, I., & Stefanis, L. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.008 · Cited by 167
Bendiske, J., & Bahr, B. A. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.5.451 · Cited by 165
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer’s disease
Rockenstein, E., Hansen, L. A., Mallory, M., Trojanowski, J. Q., Galasko, D., & Masliah, E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02772-x · Cited by 164
Self-citationα-Synuclein and the Lewy body disorders
Dickson, D. W. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00001 · Cited by 164
Small molecule enhancers of autophagy for neurodegenerative diseases
Sarkar, S., & Rubinsztein, D. C. (2008) · Molecular BioSystems · doi:10.1039/b804606a · Cited by 163
Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
Jellinger, K. A., & Attems, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0088-2 · Cited by 158
Dopamine-modified α-synuclein blocks chaperone-mediated autophagy
Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., Hodara, R., Fredenburg, R., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 144
Lee, J., & Gao, F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0924-09.2009 · Cited by 131
Fibroblast Growth Factor 1 Regulates Signaling via the Glycogen Synthase Kinase-3β Pathway
Hashimoto, M., Sagara, Y., Langford, D., Everall, I., Mallory, M. E., Everson, A., Digicaylioglu, M. H., & Masliah, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202803200 · Cited by 128
Self-citationJanvin, C. C., Larsen, J. P., Salmon, D. P., Galasko, D. R., Hugdahl, K., & Aarsland, D. (2005) · Movement Disorders · doi:10.1002/mds.20726 · Cited by 119
Self-citationAberrant Phosphorylation of α-Synuclein in Human Niemann-Pick Type C1 Disease
Saito, Y., Suzuki, K., Hulette, C. M., & Murayama, S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.323 · Cited by 98
Design and cloning of lentiviral vectors expressing small interfering RNAs
Tiscórnia, G., Singer, O., & Verma, I. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.36 · Cited by 96
Rockenstein, E. M., Schwach, G., Ingolić, E., Adame, A., Crews, L. A., Mante, M., Pfragner, R., Schreiner, E., Windisch, M., & Masliah, E. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20446 · Cited by 95
Self-citationRole of Synucleins in Alzheimer’s Disease
Crews, L. A., Tsigelny, I. F., Hashimoto, M., & Masliah, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9073-6 · Cited by 95
Self-citationHashimoto, M., Takenouchi, T., Rockenstein, E. M., & Masliah, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01791.x · Cited by 88
Self-citationMucke, L., Abraham, C. R., Ruppe, M. D., Rockenstein, E. M., Toggas, S. M., Mallory, M. E., Alford, M. F., & Masliah, E. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1551 · Cited by 88
Self-citationReduced Neuritic Outgrowth and Cell Adhesion in Neuronal Cells Transfected with Human α-Synuclein
Takenouchi, T., Hashimoto, M., Hsu, L. J., Mackowski, B., Rockenstein, E. M., Mallory, M. E., & Masliah, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0923 · Cited by 78
Self-citationFrontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
Hansen, L. A., Daniel, S. E., Wilcock, G., & Love, S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.653 · Cited by 76
Self-citationGaucher disease associated with parkinsonism: Four further case reports
Várkonyi, J., Rosenbaum, H., Baumann, N., MacKenzie, J. J., Simon, Z., Aharon‐Peretz, J., Walker, J. M., Tayebi, N., & Sidransky, E. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10028 · Cited by 70
Cortical Lewy body disease and Parkinson's disease dementia
Burn, D. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247607.34697.a2 · Cited by 65
The Lewy body variant of Alzheimer disease
Hansen, L. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_7 · Cited by 62
Self-citationAβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
Masliah, E., Alford, M. F., Adame, A., Rockenstein, E. M., Galasko, D., Salmon, D. P., Hansen, L. A., & Thal, L. J. (2003) · Neurology · doi:10.1212/01.wnl.0000073987.79060.4b · Cited by 56
Self-citationEntorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies
Hansen, L. A., Masliah, E., Quijada, S., & Rexin, D. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90478-c · Cited by 44
Self-citationVeinbergs, I., Van Uden, E., Mallory, M., Alford, M., McGiffert, C., DeTeresa, R., Orlando, R., & Masliah, E. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7684 · Cited by 29
Self-citationα-Synuclein-positive structures induced in leupeptin-infused rats
Nakajima, T., Takauchi, S., Ohara, K., Kokai, M., Nishii, R., Maeda, S., Takanaga, A., Tanaka, T., Takeda, M., Seki, M., et al. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.099 · Cited by 16
Cited by
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Self-citationAutophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity
Decressac, M., Mattsson, B., Weikop, P., Lundblad, M., Jakobsson, J., & Björklund, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305623110 · Cited by 753
Autophagy failure in Alzheimer's disease—locating the primary defect
Nixon, R. A., & Yang, D.-S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.021 · Cited by 595
Metadata
- Authors
- Crews, L., Spencer, B., Desplats, P., Patrick, C., Paulino, A., Rockenstein, E., Hansen, L., Adame, A., Galasko, D., & Masliah, E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-19
- Volume
- 5
- Issue
- 2
- Pages
- e9313
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2078207717
- Cited by
- 367
- References
- 89
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.